← All Enovix CORP filings

Enovix CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
ENVX
Enovix CORP
10-K/A: Enovix Amends 10-K for Auditor Consent Correction
Enovix Corporation filed an amendment to its annual report to correct an oversight in its auditor's consent, specifically adding references to certain S-3 registration statements.
NASDAQ
ENVX
Enovix CORP
10-K: Enovix Reports Strong 2025 Revenue Growth, Advances AI-1 Battery
Enovix Corporation achieved its highest annual revenue and gross margins to date in fiscal year 2025, driven by defense shipments and significant progress in its AI-1 battery platform and manufacturing scale-up.
NASDAQ
ENVX
Enovix CORP
10-K: Enovix Corporation Reports Fiscal Year 2024 Results, Navigates Manufacturing Transition
Enovix Corporation details its FY2024 performance, highlighting manufacturing shifts and strategic market focus amid ongoing financial losses.
NASDAQ
ENVX
Enovix CORP
10-K: Enovix Corporation Files 10-K, Detailing Progress in Advanced Lithium-ion Battery Production and Strategic Realignment
Enovix Corporation's 10-K filing reveals advancements in lithium-ion battery technology, strategic acquisitions, and a shift towards high-volume manufacturing in Asia.